On June 9, the American Cancer Society (ACS) released updated recommendations for diet and physical activity for cancer prevention. The ACS guideline was last updated in 2012. Changes to the guideline reflect the latest evidence on the impact of lifestyle on cancer risk. Approximately, 18 percent of all cancer cases in the U.S. are related to a combination of diet and physical activity factors, the ACS states.
The new guideline includes recommendations for more physical activity, eating less (or no) processed and red meat, and avoiding alcohol or drinking less.
The updated American Cancer Society Guideline for Diet and Physical Activity for Cancer Prevention was published online on June 9, in CA: A Journal for Cancer Clinicians.
Access the full article here.
Posted 6/9/2020

In a recent article from Oncology Issues, authors conducted a systematic literature review and found that two main drivers of care disparities exist for transgender and nonbinary individuals with cancer: rigid binary gender frameworks and gaps in mental health care.

2026 ACCC Innovator Award Winner St. Luke's Cancer Institute noticed a significant administrative burden being placed on providers to review medical necessity validation for complex oncology therapies. To address the resulting rise in peer-to-peer requirements, delays in care, and pre-service denials, the team designed and implemented a new Clinical Documentation Integrity Registered Nurse role.

ACCC launched its Precision Medicine Stewardship Program to highlight institutions that have successfully built the infrastructure, workflows, and leadership models needed to deliver precision medicine at scale. TriHealth Cancer and Blood Institute in Cincinnati, Ohio, offers a compelling example of what it takes to move from aspiration to execution.

Although patients with relapsed or refractory multiple myeloma now have more treatment options than ever, their journeys are often complex. As clinicians consider when to introduce newer therapies such as bispecific antibodies, they must account for prior treatments, treatment-related toxicities, and comorbidities that may impact treatment decisions.
